Silicon Valley’s biggest names are backing new ways to organize and fund science research. Some worry their experiments signal a “move fast and break things” approach.
A peer reviewed study funded by the American Gas Association (AGA) found that there is not enough evidence to demonstrate a causal relationship between
Charis Thompson berkeley.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from berkeley.edu Daily Mail and Mail on Sunday newspapers.
Aseries of disclosures in recent weeks revealed fraud and bribery in the Food and Drug Administration's (FDA) generic drug approval programs. Some lawmakers have reacted to these disturbing developments by calling for stricter FDA review of new drug approvals. FDA!sfeall problem, however, remains a drug approval process that moves too slowly, not too quickly. Over the past year, the FDA has taken several significant steps toward making new drugs available more quickly to those who need them most, such as sufferers of potentially fatal diseases, includ- ing AIDS. Only last week, for example, the FDA approved wide distribution of the anti-AIDS drug DDI, even though tests of the drug's effectiveness and side effects have not yet been com- pleted. The recent scandals should not be used as an excuse to halt or slow these actions.
The MIT Series Patrick Collison and Tyler Cowen opened their 2019 Atlantic piece that helped jump-start the progress studies movement with the following passage: In 1861, the American scientist and educator William Barton Rogers published a manifesto calling for a new kind of research institution. Recognizing the “daily increasing proofs of the happy influence of scientific culture on the industry and the civilization of the nations,” and the growing importance of what he called “Industrial Arts,” he proposed a new organization dedicated to practical knowledge. He named it the Massachusetts Institute of Technology.